Search

everythinglearnresearchcommunity

for

Search:↓

Effective treatments for severe alopecia areata are still lacking.

CD2 might be a new treatment target for patchy alopecia areata.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Immunotherapy can help treat severe alopecia areata.

Rituximab can cause skin issues, but baricitinib may help improve them.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher antigliadin antibody levels are linked to alopecia areata severity.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Low vitamin D levels are common in people with Alopecia Areata.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Stopping azathioprine improved hair loss and bone marrow issues.

Leukocyte-rich platelet-rich plasma is safe and can potentially help treat scarring hair loss.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Misdiagnosis of LPP in AGA patients can cause hair transplant issues.

Oral zinc and Nd:YAG laser therapy effectively treated primary cicatricial alopecia in five patients.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.